Your browser doesn't support javascript.
loading
High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.
Dower, Ken; Zhao, Shanrong; Schlerman, Franklin J; Savary, Leigh; Campanholle, Gabriela; Johnson, Bryce G; Xi, Li; Nguyen, Vuong; Zhan, Yutian; Lech, Matthew P; Wang, Ju; Nie, Qing; Karsdal, Morten A; Genovese, Federica; Boucher, Germaine; Brown, Thomas P; Zhang, Baohong; Homer, Bruce L; Martinez, Robert V.
Afiliação
  • Dower K; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Zhao S; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Schlerman FJ; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Savary L; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.
  • Campanholle G; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Johnson BG; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Xi L; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Nguyen V; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.
  • Zhan Y; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.
  • Lech MP; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Wang J; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Nie Q; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.
  • Karsdal MA; Nordic Bioscience A/S, Herlev, Denmark.
  • Genovese F; Nordic Bioscience A/S, Herlev, Denmark.
  • Boucher G; Drug Safety, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America.
  • Brown TP; Drug Safety, Pfizer Worldwide Research and Development, Groton, Connecticut, United States of America.
  • Zhang B; Clinical Bioinformatics, Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
  • Homer BL; Drug Safety, Pfizer Worldwide Research and Development, Andover, Massachusetts, United States of America.
  • Martinez RV; Inflammation and Immunology, Pfizer Worldwide Research and Development, Cambridge, Massachusetts, United States of America.
PLoS One ; 12(7): e0181861, 2017.
Article em En | MEDLINE | ID: mdl-28746409
ABSTRACT
ZSF1 rats exhibit spontaneous nephropathy secondary to obesity, hypertension, and diabetes, and have gained interest as a model system with potentially high translational value to progressive human disease. To thoroughly characterize this model, and to better understand how closely it recapitulates human disease, we performed a high resolution longitudinal analysis of renal disease progression in ZSF1 rats spanning from early disease to end stage renal disease. Analyses included metabolic endpoints, renal histology and ultrastructure, evaluation of a urinary biomarker of fibrosis, and transcriptome analysis of glomerular-enriched tissue over the course of disease. Our findings support the translational value of the ZSF1 rat model, and are provided here to assist researchers in the determination of the model's suitability for testing a particular mechanism of interest, the design of therapeutic intervention studies, and the identification of new targets and biomarkers for type 2 diabetic nephropathy.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Rim / Falência Renal Crônica Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Rim / Falência Renal Crônica Idioma: En Ano de publicação: 2017 Tipo de documento: Article